New antibody trial aims to help immune system fight advanced cancers
NCT ID NCT04725474
Summary
This trial is testing a new drug called CTL-002 (visugromab) for adults with advanced solid tumors that have returned or stopped responding to standard treatments, including immunotherapy. The study has two parts: first finding a safe dose, then testing that dose in combination with an approved immunotherapy drug across seven specific cancer types. The main goals are to check the safety of the drug and see if it can help shrink tumors or stop them from growing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica Universidad de Navarra, Unidad Central de Ensayos Clinicos
Pamplona, 31008, Spain
-
Hospital Universitari Vall d'Hebron, Institute of Oncology
Barcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
ICMDiM, Hospital Clinic
Barcelona, 08036, Spain
-
ICO Hospitalet, Hospital Duran i Reynals
Barcelona, 08908, Spain
-
Kantonsspital St. Gallen, Clinic for Medical Oncology & Hematology
Sankt Gallen, 9007, Switzerland
-
Next Oncology, Phase I Unit. IOB - Hospital Quironsalud
Barcelona, 08023, Spain
-
START Madrid, Hospital Universitario HM Sanchinarro
Madrid, 28050, Spain
-
University Hospital Basel, Department for Medical Oncology
Basel, 4031, Switzerland
-
University Hospital Zurich, Department of Dermatology
Zurich, 9091, Switzerland
-
Universitätsklinikum Essen, Westdeutsches Tumorzentrum, Innere Klinik und Poliklinik
Essen, 45147, Germany
-
Universitätsklinikum Frankfurt, Medizinische Klinik I
Frankfurt am Main, 60590, Germany
-
Universitätsklinikum Würzburg, Comprehensive Cancer Center
Würzburg, 97078, Germany
Conditions
Explore the condition pages connected to this study.